Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	29.79	73.20	56.40
Graham Fair Price	-16.21	13.97	16.67
PEG	-84.76	-1.01	-0.54
Price/Book	-13.92	1.05	1.22
Price/Cash Flow	39.97	55.56	39.69
Prices/Earnings	19.96	30.76	25.64
Price/Sales	-17.20	24.47	29.56
Price/FCF	39.97	55.56	39.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-0.04	0.96	0.96
Operating Margin	162.59	0.02	< 0.005
ROA	-28.63	< 0.005	< 0.005
ROE	0.01	< 0.005	-28.25
ROIC	< 0.005	< 0.005	174.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.06	-99.09
Dividends QOQ	< 0.005	< 0.005	-15.12
EBIT QOQ	-0.98	1.70	72.81
EPS QOQ	-0.47	-0.31	35.07
FCF QOQ	0.69	-0.39	-43.44
Revenue QOQ	< 0.005	0.03	2064.31
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-613.73	-100.00
Days Sales Outstanding (DSO)	32.70	24.64	-24.64
Inventory Turnover	0.00	-0.15	-100.00
Debt/Capitalization	0.46	0.46	0.60
Quick Ratio	1.07	35.21	3175.41
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	32.18	31.83	-1.08
Cash	1.24	57.09	4514.50
Capex	-0.14	-0.20	-44.78
Free Cash Flow	0.99	0.60	-39.17
Revenue	1.33	1.37	2.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.25	1.08	-13.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.34	32.05	43.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating